Altered p53 and Bcl-2 expression in keratinocytes of vulvar lichen sclerosus during pimecrolimus treatment.
Nissi
R
R
Kotila
V
V
Knuuti
E
E
Väre
P O
PO
Kauppila
S
S
D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015603:Keratinocytes / Q000378:metabolism; D011230:Precancerous Conditions / Q000378:metabolism*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism*; D016559:Tacrolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016159:Tumor Suppressor Protein p53 / Q000187:drug effects* / Q000378:metabolism; D007724:Vulvar Lichen Sclerosus / Q000188:drug therapy / Q000378:metabolism*
D007166:Immunosuppressive Agents; D019253:Proto-Oncogene Proteins c-bcl-2; D016159:Tumor Suppressor Protein p53; C117268:pimecrolimus; D016559:Tacrolimus